GHRP-6: Dosage, Benefits & Research Guide
What is GHRP-6?
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that functions as a potent ghrelin receptor (GHS-R1a) agonist, stimulating the anterior pituitary to release growth hormone in a pulsatile manner. Its mechanism involves both direct pituitary stimulation and hypothalamic amplification through GHRH neurons, producing robust GH elevations that mimic natural secretory patterns. Research published in the Journal of Endocrinology demonstrated that GHRP-6 administration in animal models produced significant GH release within 15-30 minutes, with peak levels 5-10 times above baseline. Studies by Bowers et al. (1991) were among the first to characterize its GH-releasing potency. Notably, research in Neuroscience Letters has indicated neuroprotective properties in ischemic brain injury models, where GHRP-6 reduced infarct volume and improved neurological outcomes through anti-apoptotic pathways. Compared to other GH secretagogues like Ipamorelin and GHRP-2, GHRP-6 produces the strongest appetite-stimulating effect due to its ghrelin-mimetic activity. It also raises cortisol and prolactin to a greater degree than Ipamorelin, making it less selective but more potent in overall GH output. GHRP-2 shares similar potency but with slightly reduced hunger effects. For storage, lyophilized GHRP-6 should be kept at -20C for long-term preservation. Once reconstituted with bacteriostatic water, store at 2-8C and use within 4 weeks. This peptide is widely studied by endocrinologists, neuroscientists investigating ischemia-reperfusion injury, and researchers examining growth hormone physiology and appetite regulation pathways.
GHRP-6 Research Applications
In published and preclinical research, GHRP-6 has been studied across the following areas:
- Cognitive function and memory studies
- Neuroprotection in ischemia models
- Wound healing and collagen formation
- Cardiovascular protection research
GHRP-6 in Research: Reconstitution & Study Concentrations
GHRP-6 is supplied as a lyophilized powder. For laboratory research it is reconstituted with bacteriostatic or sterile water; the solvent volume sets the working concentration. Published studies select concentrations specific to the assay or model system — there is no human dose, as GHRP-6 is not approved for human use. Researchers should reference the primary literature for the model in question and document the exact lot COA.
Worked example: a 10mg vial reconstituted with 2 mL of bacteriostatic water yields 5.00 mg/mL.
Open the reconstitution calculator